Effect of intermittent systemic corticosteroid on bone metabolism in bronchial asthma patients

Journal of Asthma

Volumn 46, Issue 2, 2009, Pages 142-146

  Mori, Hidenori ^a   Tanaka, Haruhito ^b   Ohno, Yasushi ^a   Ito, Fumitaka ^a   Funaguchi, Norihiko ^a   Endo, Junki ^a   La, Bu Lin Bai ^a   Minatoguchi, Shinya ^a  

^a GIFU UNIVERSITY   (Japan)

^b Gifu Red Cross Hospital   (Japan)

Author keywords

Bronchial asthma; Inhaled corticosteroid; Osteoporosis; Systemic corticosteroid

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; BIOCHEMICAL MARKER; CORTICOSTEROID; PREDNISOLONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; PEPTIDE;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CALCULATION; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFECT; DRUG INTERMITTENT THERAPY; FEMALE; HUMAN; IMAGE PROCESSING; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; OSTEOPOROSIS; RESPIRATORY FUNCTION; RISK FACTOR; SHORT COURSE THERAPY; AGED; BLOOD; BODY HEIGHT; BONE; CHEMICALLY INDUCED DISORDER; FORCED EXPIRATORY VOLUME; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ADULT; AGED; ASTHMA; BODY HEIGHT; BONE AND BONES; BONE DENSITY; COLLAGEN TYPE I; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PEPTIDES; RISK FACTORS; YOUNG ADULT;

EID: 63149162309     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900802492095     Document Type: Article

References (21)

1. Goldstein MF, Fallon JJ Jr, Harning R. Chronic glucocoriticoid therapy- induced osteoporosis in patients with obstructive lung disease. Chest 1999; 116:1733-1749. (Pubitemid 30012719)
2. Japanese society of Allergology. Asthma Prevention and Management Guidelines. Tokyo, 2006.
3. Adinoff AD, Hollister JR. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 1983; 309:265-268.
4. Nawata H, Soen S, Takayanagi R, Tanaka I, Takaoka K, Fukunaga M, Matsumoto T, Suzuki Y, Tanaka H, Fujiwara S, Miki T, Sagawa A, Nishizawa Y, Seino Y. The Subcommittee to Study Diagnostic Criteria for Glucocorticoid- Induced Osteoporosis. Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004). J Bone Miner Metab 2005; 23:105- 109.
5. Siminoski K, Jiang G, Adachi JD, Hanley DA, Cline G, Ioannidis G, Hodsman A, Josse RG, Kendler D, Olszynski WP, Ste Marie LG, Eastell R. Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures. Osteoporos Int. 2005; 4:403-410. (Pubitemid 40487398)
6. Koh LK, Sedrine WB, Torralba TP, Kung A, Fujiwara S, Chan SP, Huang QR, Rajatanavin R, Tsai KS, Park HM, Reginster JY; Osteoporosis Self- Assessment Tool for Asians (OSTA) Research Group. A simple tool to identify Asian women at increased risk of osteoporosis. Osteoporosis Int 2001; 12:699-705.
7. Nishizawa Y, Nakamura T, Ohta H, Kushida K, Gorai I, Shiraki M, Fuku- naga M, Hosoi T, Miki T, Chaki O, Ichimura S, Nakatsuka K, Miura M. Committee on the Guidelines for the Use of Biochemical Markers of Bone Turnover in Osteoporosis Japan Osteoporosis Society. Guidelines for the use of biochemical markers of bone turnover in osteoporosis. J Bone Miner Metab 2005; 23:97-104.
8. Yoshimura N, Nakatsuka K, Saitou S, Nishizawa K, Uchiyama M, Miura M. Serum cross-linked N-telopeptide of type I collagen (NTX) and serum amino-terminal propeptide of type I procollagen (PINP) in residents of a rural community in Japan: Age and sex-related values and reference limits. Osteoporosis Jpn 2002.10: 539-544.
9. Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara S, Shiraki M, Kushida K, Miyamoto S, Soen S, Nishimura J, Oh-Hashi Y, Hosoi T, Gorai I, Tanaka H, Igai T, Kishimoto H; Osteoporosis Diagnostic Criteria Review Commit- tee: Japanese Society for Bone and Mineral Research. Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 2001; 19:331-337.
10. Dahl R. Systemic side effects of inhaled corticosteroids inpatients with asthma. Respir Med 2006; 100:1307-1317. (Pubitemid 43942329)
11. Halpern MT, Schmier JK, Van Kerkhove MD, Watkins M, Kalberg CJ. Impact of long-term inhaled corticosteroid therapy on bone mineral den- sity: results of meta-analysis. Ann Allergy Asthma Immunol 2004; 92:201- 207.
12. Chang DJ, Ji C, Kim KK, Casinghino S, McCarthy TL, Centrella M. Re- duction in transforming growth factor beta receptor 1 expression and tran- scription factor CBFa 1 on bone cells by glucocorticoid. J Biol Chem 1998; 273:4892-4896. (Pubitemid 28108639)
13. Gohel A, McCarthy MB, Gronowicz G. Estrogen prevents glucocorticoid- induced apoptosis in osteoblasts in vivo and in vitro. Endocrinology 1999; 140:5339-5347. (Pubitemid 30687145)
14. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblas- togenesis and promotion of apoptosis of osteoblasts and osteocytes by glu- cocorticoids. J Clin Invest 1998; 102:274-282.
15. Weinstein RS, Chen J, Powers CC, Stewart SA, Landes RD, Bellido T, Jilka RL, Parfitt AM, Manolagas SC. Promotion of osteoclast survival and antag- onism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J Clin Invest 2002; 109:1041-1048. (Pubitemid 34408579)
16. Fujita K, Kasayama S, Hashimoto J, Nagasaka Y, Nakano N, Morimoto Y, Barnes PJ, Miyatake A. Inhaled corticosteroids reduce bone mineral density in early postmenopausal but not premenopausal asthmatic women. J Bone Miner Res 2001; 16:782-787. (Pubitemid 32230608)
17. Saag KG, Shane E, Boonen S, Marin F, Donley DW, Taylor KA, Dalsky GP, Marcus R. Teriparatide or alendronate in glucocorticoid-induced osteo- porosis. N Engl J Med 2007; 357:2028-2039. (Pubitemid 350106710)
18. Van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid- induced osteoporosis ; a meta-analysis. Osteoporosis Int 2002; 13:777- 787. (Pubitemid 36336722)
19. Gourlay M, Franceschini N, Sheyn Y. Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures. Clin Rheumatol; 2007; 26:144-153. (Pubitemid 46020234)
20. Godschalk M, Downs RW. Effect of short-term glucocorticoids on serum osteocalcin in healthy young men. J Bone Miner Res 1988; 3:113-115. (Pubitemid 18210534)
21. Dovio A, Perazzolo L, Osella G, Ventura M, Termine A, Milanio E, Bertold A, Angeli A.Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis. J Clin Endocrinol Metab 2004; 89:49234928. (Pubitemid 39391429)